Status:
UNKNOWN
Sphenopalatine Block Versus Greater Occipital Nerve Block in PDPH
Lead Sponsor:
Ain Shams University
Conditions:
Post-Dural Puncture Headache
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Management of postdural puncture headache (PDPH) has always been challenging for anesthesiologists. PDPH not only increases the misery of the patient, but the length of stay and overall cost of treatm...
Eligibility Criteria
Inclusion
- Obstetric patients ( American Society of Anesthesiologists ) ASA I\&II ,body weight between 60-100kg expressing PDPH after spinal anesthesia, (VAS \> 4 ) with standard treatment such as intravenous fluids, abdominal binder, bed rest and caffeine.
Exclusion
- • ASA III\& IV patients.
- Refusal of the patient.
- Patients with chronic headache or migraine.
- Hypertensive patients.
- A patient that cannot comply with the VAS.
- Infection at site of the block
- Known coagulation defect.
- Nasal septal deviation, polyp, history of nasal bleeding.
- Allergy to local anaesthetics.
Key Trial Info
Start Date :
January 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05235256
Start Date
January 10 2022
End Date
December 1 2022
Last Update
November 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University Hospital
Cairo, Egypt